Literature DB >> 34303819

Formulation, process, and storage strategies for lyophilizates of lipophilic nanoparticulate systems established based on the two models paliperidone palmitate and solid lipid nanoparticles.

Eduard Trenkenschuh1, Ula Savšek1, Wolfgang Friess2.   

Abstract

Lyophilization formulation and process development for lipophilic nanoparticle (NPs) products is highly challenging as the NPs have a low colloidal stability. We compared two different NP types, pure paliperidone palmitate nanocrystals and trimyristin solid lipid nanoparticles regarding formulation, process, and storage stability aspects. Freeze-thaw studies were conducted to investigate the basic formulation aspects such as buffer type, pH, and ionic strength as well as different cryoprotectants. In freeze-drying conventional ramp freezing was performed and compared to freezing with an annealing step added or with controlled ice nucleation. Different formulations were lyophilized and tested for short-term storage stability up to 6 weeks. Samples were analyzed for particle size, subvisible particle number, specific surface area, residual moisture, crystallinity, and glass transition temperature. Sucrose significantly better stabilized both NP types against freeze-thaw stress compared to mannitol demonstrating the importance of a fully amorphous matrix. While the impact of buffer type and pH was negligible, the aggregation propensity of NPs was reduced in presence of NaCl. The freezing step also impacted NP aggregation but the effect was less important than the formulation design. Surfactants did not necessarily improve the colloidal stability but resulted in a lower glass transition temperature of the lyophilizates and may cause phase separation which limits storage stability. This hurdle can be overcome by using a hydroxypropyl-β-cyclodextrin/ sucrose mixture as cryoprotectant. In general, we could show a similar freeze-drying behavior of the two NP types. Thus, we established a formulation and process approach to achieve stable lyophilizates of lipophilic NPs based on two different types of NPs. The general rules should be transferable to other NPs facilitating lyophilization development.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Buffer type; Drug nanosuspension; Freeze-drying; Freeze-thaw; Ionic strength; Process stability; Solid lipid nanoparticles; Stability testing

Year:  2021        PMID: 34303819     DOI: 10.1016/j.ijpharm.2021.120929

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  2 in total

1.  Preparation of Naringenin Nanosuspension and Its Antitussive and Expectorant Effects.

Authors:  Zhengqi Dong; Rui Wang; Mingyue Wang; Zheng Meng; Xiaotong Wang; Meihua Han; Yifei Guo; Xiangtao Wang
Journal:  Molecules       Date:  2022-01-24       Impact factor: 4.411

Review 2.  Engineering nano-drug biointerface to overcome biological barriers toward precision drug delivery.

Authors:  Saquib Waheed; Zhibin Li; Fangyingnan Zhang; Anna Chiarini; Ubaldo Armato; Jun Wu
Journal:  J Nanobiotechnology       Date:  2022-08-31       Impact factor: 9.429

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.